The authors showed significantly higher expression of FPR2 in the hepatocytes and livers of WT female mice than in WT male mice and that this female-specific FPR2 in hepatocytes protected these cells from lipotoxicity, contributing to the resistance to NAFLD development and severity in female mice. Here, FPR2 is linked to metabolic dysfunction-associated steatotic liver disease.